# Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin

> **NCT04794348** · PHASE2 · WITHDRAWN · sponsor: **Teleflex**

## Conditions studied

- Anticoagulant Reversal

## Interventions

- **BIOLOGICAL:** Fresh Frozen Plasma (FFP)
- **BIOLOGICAL:** Freeze Dried Plasma (FDP)

## Key facts

- **NCT ID:** NCT04794348
- **Lead sponsor:** Teleflex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was never started and is no longer planned for execution. We are now in the process of aligning to a new study design with the FDA.
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04794348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04794348, "Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04794348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*